QUAD is MEDVi's compounded multi-ingredient ED program: a dissolvable sublingual treatment combining multiple active ingredients in one dose, prescribed only after a licensed provider reviews your health information.

Who it tends to fit

Based on the program's design, QUAD is most relevant for men who haven't had consistent results with single-ingredient tablets, or who prefer a dissolvable format — the premium subscription pricing makes most sense in those cases. First-timers may be better served starting with a provider conversation about standard options.

The model

Online intake, licensed-provider review, and — if prescribed — subscription delivery in discreet packaging with ongoing provider access. MEDVi operates as a LegitScript-certified telehealth provider; final pricing and availability are shown on their site before enrollment and vary by state.

About compounded medications: compounded drugs are not FDA-approved, and the FDA does not verify their safety or effectiveness. A licensed provider decides whether any treatment is appropriate for you.